EEF2K anticorps (AA 1-238)
Aperçu rapide pour EEF2K anticorps (AA 1-238) (ABIN1885825)
Antigène
Voir toutes EEF2K AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-238
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 1 and 238 of EEF2K
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.50-1.500
Immunofluorescence: 1.100-1.200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- EEF2K (Eukaryotic Elongation Factor-2 Kinase (EEF2K))
-
Autre désignation
- EEF2K
-
Sujet
-
This gene encodes a highly conserved protein kinase in the calmodulin-mediated signaling pathway that links activation of cell surface receptors to cell division.This kinase is involved in the regulation of protein synthesis.It phosphorylates eukaryotic elongation factor 2 (EEF2) and thus inhibits the EEF2 function.The activity of this kinase is increased in many cancers and may be a valid target for anti-cancer treatment.[provided by RefSeq]
-
Poids moléculaire
- 82 kDa
-
ID gène
- 29904
-
NCBI Accession
- NM_013302, NP_037434
-
Pathways
- AMPK Signaling
Antigène
-